$87.17
1.34% today
NYSE, Jun 30, 10:14 pm CET
ISIN
IE00BTN1Y115
Symbol
MDT

Medtronic Stock price

$87.17
+4.19 5.05% 1M
+7.56 9.50% 6M
+7.29 9.13% YTD
+10.05 13.03% 1Y
-2.58 2.87% 3Y
-4.53 4.94% 5Y
+13.07 17.64% 10Y
+35.38 68.31% 20Y
NYSE, Closing price Mon, Jun 30 2025
+1.15 1.34%
ISIN
IE00BTN1Y115
Symbol
MDT
Sector

Key metrics

Basic
Market capitalization
$110.2b
Enterprise Value
$129.8b
Net debt
$19.6b
Cash
$9.0b
Shares outstanding
1.3b
Valuation (TTM | estimate)
P/E
23.76 | 15.35
P/S
3.29 | 3.09
EV/Sales
3.87 | 3.64
EV/FCF
25.03
P/B
2.30
Dividends
DPS
$2.80
Yield 1Y | 5Y
3.26% | 2.73%
Growth 1Y | 5Y
1.45% | 5.33%
Payout 1Y | 3Y
77.56% | 90.10%
Increased
25 Years
Financials (TTM | estimate)
Revenue
$33.5b | $35.7b
EBITDA
$8.4b | $10.5b
EBIT
$6.6b
Net Income
$4.7b | $7.2b
Free Cash Flow
$5.2b
Growth (TTM | estimate)
Revenue
3.62% | 6.32%
EBITDA
8.14% | 22.89%
EBIT
8.51%
Net Income
26.85% | 54.07%
Free Cash Flow
-0.29%
Margin (TTM | estimate)
Gross
65.48%
EBITDA
25.19% | 29.38%
EBIT
19.80%
Net
13.90% | 20.15%
Free Cash Flow
15.46%
Financial Health
Equity Ratio
52.38%
Return on Equity
9.71%
ROCE
8.43%
ROIC
7.02%
Debt/Equity
0.59
More
EPS
$3.62
FCF per Share
$4.04
Short interest
0.66%
Employees
95.00k
Rev per Employee
$350.00k
Show more

Is Medtronic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

Medtronic Stock Analysis

Unlock Scores for Free

Analyst Opinions

38 Analysts have issued a Medtronic forecast:

20x Buy
53%
16x Hold
42%
2x Sell
5%

Analyst Opinions

38 Analysts have issued a Medtronic forecast:

Buy
53%
Hold
42%
Sell
5%

Financial data from Medtronic

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Apr '25
+/-
%
33,537 33,537
4% 4%
100%
- Direct Costs 11,576 11,576
4% 4%
35%
21,961 21,961
3% 3%
65%
- Selling and Administrative Expenses 10,818 10,818
2% 2%
32%
- Research and Development Expense 2,718 2,718
1% 1%
8%
8,449 8,449
8% 8%
25%
- Depreciation and Amortization 1,807 1,807
7% 7%
5%
EBIT (Operating Income) EBIT 6,642 6,642
9% 9%
20%
Net Profit 4,663 4,663
27% 27%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Medtronic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medtronic Stock News

Positive
Seeking Alpha
one day ago
Initiate Medtronic with Strong Buy, $161 PT, citing a structural margin inflection from Diabetes spin-off and robust innovation pipeline (120+ approvals). Street underestimates FY27 margin/EPS upside from Diabetes separation and operating leverage in Cardiac & Structural Heart—key drivers for re-rating. Valuation at 26x FY27E EPS is conservative versus peers; scenario analysis shows risk skewed...
Positive
Seeking Alpha
2 days ago
I reiterate my buy rating on Medtronic, driven by solid fundamentals and an attractive valuation, despite less upside versus prior estimates. Medtronic continues to deliver steady revenue growth, robust free cash flow, and a 48-year dividend growth streak, even as sector sentiment weakens. Key risks include competitive pressures, margin threats in Diabetes and CAS, and macro headwinds like tari...
Positive
The Motley Fool
4 days ago
The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
More Medtronic News

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Head office United States
CEO Geoffrey Martha
Employees 95,000
Founded 2014
Website www.medtronic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today